-
LPS ELISA Troubleshooting: The Importance of Sample Nature(Post)
Quick answer A researcher measuring circulating lipopolysaccharide (LPS) in human serum with our LPS ELISA saw almost no color, even after 30 minutes with substrate. Samples had been test
Sofort anwendbar: Probenverdünnung berechnen für Laborpraxis(Post)Sofort anwendbar: Probenverdünnung berechnen für Laborpraxis Die Verdünnung berechnen Sie mit der Formel C1·V1 = C2·V2. Meist suchen Sie V1, also das Volumen der Ausgangslösung: V1 = (C2·V2)/C1. Wich
Antikörpervalidierung: So weisen Sie Spezifität wirklich nach(Post)Antikörpervalidierung: So weisen Sie Spezifität wirklich nach Das eigentliche Ziel ist, Off-Target-Bindung und falsch-positive Signale zu minimieren, bevor sie ein ganzes Projekt verzerren. Dafür bra
DNA Assembly Cloning(Page) TA Cloning(Page) Vibostolimab: Mechanism, Clinical Applications, and Research Potential in Oncology(Post)Key Facts About VibostolimabWhat is Vibostolimab?Vibostolimab is an anti-TIGIT monoclonal antibody developed by Merck, targeting immune checkpoint pathways to enhance anti-tumor immunity
Enapotamab: Advancing Cancer Research with Innovative Therapeutics(Post)Quick Facts About EnapotamabWhat is Enapotamab?Enapotamab is an experimental antibody-drug conjugate (ADC) developed to target tumor cells selectively, offering new hope in cancer treatm
Lusvertikimab: Unveiling the Potential in Immuno-Oncology(Post)What You Need to Know About LusvertikimabWhat is Lusvertikimab?Lusvertikimab is a monoclonal antibody designed to inhibit the IL-4 receptor, a key player in regulating immune responses,
COVID-19 (SARS-CoV-2) Assay Tests(Post)Rapid Antibody & Antigen tests available from Assay Genie
Varlilumab: Unlocking CD27’s Potential in Cancer Research(Post)What You Need to Know About VarlilumabWhat is Varlilumab?Varlilumab is a monoclonal antibody targeting CD27, a receptor on T-cells that plays a critical role in immune modulation.What is
Tigatuzumab: Advancing Cancer Research with Targeted Therapies(Post)Quick Facts About TigatuzumabWhat is Tigatuzumab?Tigatuzumab is a monoclonal antibody that targets the death receptor 5 (DR5) pathway, inducing apoptosis in cancer cells.What is the mech
Patritumab Deruxtecan: Mechanism, Clinical Applications, and Biosimilar Advances(Post)Quick Facts About Patritumab DeruxtecanWhat is Patritumab Deruxtecan?Patritumab Deruxtecan (HER3-DXd) is an investigational antibody-drug conjugate (ADC) targeting HER3, a receptor impli
Dupilumab: Transforming Immunotherapy and Skin Disease Management(Post)What You Need to Know About DupilumabWhat is Dupilumab?Dupilumab is a fully human monoclonal antibody designed to treat various chronic inflammatory diseases by inhibiting key cytokines
CTLA-4 in Breast Cancer: Insights for Immunotherapy(Post)The Role of CTLA-4 in Breast Cancer: Implications for ImmunotherapyBreast cancer (BC) remains one of the most prevalent malignancies affecting women worldwide, with significant morbidity and mortality
Lot-zu-Lot-Variabilität: Wann Sie neue Chargen wirklich prüfen müssen(Post)Lot-zu-Lot-Variabilität: Wann Sie neue Chargen wirklich prüfen müssen Ja, Lot-zu-Lot-Variabilität ist ein reales analytisches Risiko und keine theoretische Fußnote in einem Qualitätshandbuch. Prüfen
Cytokine Storms: What happens when the immune system overreacts?(Post)Immunology · HyperinflammationCytokine Storm and Cytokine Release Syndrome: Mechanisms, Triggers and MarkersA cytokine storm is a self-amplifying inflammatory response in which cytokine release drives
Inter-Assay vs. Intra-Assay: Präzision richtig berechnen(Post)Inter-Assay vs. Intra-Assay: Präzision richtig berechnen Intra-Assay-Präzision misst, wie stark Duplikate innerhalb eines einzigen Laufs streuen. Inter-Assay-Präzision misst die Schwankung zwischen m
Mit 20–30 Blankreplikaten: LoD/LoQ korrekt berechnen für Ihr Labor(Post)Mit 20–30 Blankreplikaten: LoD/LoQ korrekt berechnen für Ihr Labor LoB, LoD und LoQ bilden eine feste Rangordnung: LoB ≤ LoD ≤ LoQ. LoD beantwortet die Frage „Ist die Substanz überhaupt nachweisbar?“
What I learnt from meeting 1000+ researchers(Post)Over the past few years I have traversed through academia in a few different guises, first as a PhD student for about 5 years, then onto the traditional route of a post-doc, followed by a sales
Targeting Immune Checkpoints as Cancer Therapy(Post)In recent years, the field of oncology has witnessed a paradigm shift with the advent of immunotherapy, a treatment modality that harnesses the body's immune system to combat cancer. Among the mos